{
    "response": "Based on your clinical data and the available medical literature, I can provide you with specific guidance on lifestyle changes to help prevent further damage to your eyes, particularly given your diagnosis of left eye primary acute angle-closure glaucoma and senile cataract.\n\n**Understanding Your Condition**\n\nFirst, it's important to understand that you experienced an acute angle-closure glaucoma attack in your left eye, which is a medical emergency where the drainage angle of your eye suddenly becomes blocked, causing a rapid increase in eye pressure. This led to your symptoms of eye pain, blurred vision, redness, photophobia, tearing, headache, and nausea. Your examination showed significantly elevated intraocular pressure (IOP) in the left eye (T+2), corneal edema, shallow anterior chamber, and other signs consistent with this diagnosis.\n\n**Lifestyle Recommendations Based on Medical Evidence**\n\nWhile the provided medical literature focuses primarily on primary open-angle glaucoma, several principles apply to your situation:\n\n1. **Regular Follow-up Care**: The consensus guidelines emphasize that patients with glaucoma require regular monitoring. Based on your acute episode and the severity of your condition, you will likely need more frequent follow-up visits initially. The guidelines recommend follow-up intervals ranging from 1-6 months depending on whether target IOP is achieved and whether there's progression of damage.\n\n2. **Medication Management**: If you're prescribed glaucoma medications, it's crucial to use them exactly as directed. The literature emphasizes educating patients about proper administration techniques, including eyelid closure or nasolacrimal occlusion when applying topical medications to reduce systemic absorption. You should alert your ophthalmologist about any physical or emotional changes that occur when taking these medications.\n\n3. **Exercise Considerations**: One study mentioned in the literature suggests that higher intensity exercise may reduce the risk of developing glaucoma. While this research focused on open-angle glaucoma prevention, maintaining good cardiovascular health through appropriate exercise may be beneficial. However, you should discuss specific exercise recommendations with your ophthalmologist, as certain positions or activities might affect eye pressure.\n\n4. **Avoid Unproven Treatments**: The literature clearly states there is no conclusive scientific evidence that herbal medicines or nutritional supplements are beneficial in treating glaucoma. Similarly, marijuana has not been shown to provide increased benefit or diminished risk compared with conventional medications. You should rely on evidence-based treatments prescribed by your ophthalmologist.\n\n5. **Surgical Considerations**: If you require or have undergone surgery, be aware that filtration surgery places the eye at lifelong risk for endophthalmitis. You should immediately notify your ophthalmologist if you experience symptoms of pain, decreased vision, redness, or discharge.\n\n**Specific Recommendations for Your Situation**\n\nGiven your acute angle-closure episode, you should:\n- Attend all scheduled follow-up appointments\n- Take all prescribed medications exactly as directed\n- Report any recurrence of symptoms (eye pain, blurred vision, redness) immediately\n- Discuss with your ophthalmologist whether cataract surgery might be recommended, as removing the cataract can sometimes help prevent future angle-closure episodes\n- Maintain good overall health through appropriate exercise and a balanced diet\n- Avoid self-treatment with unproven supplements or alternative therapies\n\n**Next Steps**\n\nYour most important lifestyle change is committing to regular ophthalmologic care. Glaucoma management typically requires lifelong monitoring and treatment. Work closely with your ophthalmologist to establish a target IOP and follow-up schedule tailored to your specific needs. Given your recent acute episode, you'll likely need more frequent monitoring initially to ensure your eye pressure remains controlled and no further damage occurs.\n\nRemember that successful glaucoma management depends on partnership between you and your eye care team. By following their recommendations consistently and maintaining open communication about any concerns or side effects, you can help protect your remaining vision.",
    "context": [
        {
            "id": 0,
            "source": "PPP Summary Benchmarks24glaucoma",
            "content": "## Primary Open-Angle Glaucoma (Initial Evaluation) (continued)\n- Follow-up evaluation on the first postoperative day and at least once during the first 1 to 2 weeks to evaluate visual acuity, IOP, and status of the anterior segment\n- In the absence of complications, perform additional postoperative visits during a 3-month period to evaluate visual acuity, IOP, and status of the anterior segment\n- Schedule more frequent follow-up visits, as necessary, for patients with postoperative complications (flat or shallow anterior chamber, early bleb failure, increased inflammation, or Tenon’s cyst)\n- Undertake additional treatments as necessary to improve aqueous flow into the bleb and lower IOP if evidence of bleb failure develops, including injection of antifibrotic agents, bleb massage, suture adjustment, release or lysis, or bleb needling\n- Manage postoperative complications as they develop, such as repair of bleb leak or reformation of a flat anterior chamber\n- Explain that filtration surgery places the eye at risk for endophthalmitis for the duration of the patient’s life, and that if the patient has symptoms of pain and decreased vision and the signs of redness and discharge he or she should notify the ophthalmologist immediately\n### Patient Education for Patients with Medical Therapy\n- Discuss diagnosis, severity of the disease, prognosis and management plan, and likelihood of lifelong therapy\n- Educate about eyelid closure or nasolacrimal occlusion when applying topical medications to reduce systemic absorption\n- Encourage patients to alert their ophthalmologist to physical or emotional changes that occur when taking glaucoma medications\n## Primary Open-Angle Glaucoma (Follow-up Evaluation)\n### Follow-up Exam History\n- Interval ocular history\n- Interval systemic medical history\n- Side effects of ocular medications\n- Review of pertinent medication use, including time of last administration\n### Follow-up Physical Exam\n- Visual acuity measurement\n- Slit-lamp biomicroscopy\n- IOP measurement\n- Perform gonioscopy if there is a suspicion of angle-closure component, anterior chamber shallowing or anterior chamber angle abnormalities, or if there is an unexplained change in IOP. Perform gonioscopy periodically\n- ONH and visual field evaluation\n### Adjustment of Therapy\n- Target IOP is not achieved and benefits of a change in therapy outweigh the risks\n- Progressive optic nerve damage despite achieving the target IOP\n- Patient's intolerant of the prescribed medical regimen\n- Contraindications to individual medications develop\n- Stable optic nerve status and low IOP occur for a prolonged period in a patient taking topical ocular hypotensive agents. Under these circumstances, a carefully monitored attempt to reduce the medical regimen may be appropriate\n- Downward adjustment of target pressure can be made in the face of progressive optic disc, imaging, or visual field change\n- Upward adjustment of target pressure can be considered if the patient has been stable and if the patient either requires or desires less medication\n### Patient Education\n- Educate about the disease process, the rationale and goals of intervention, the status of their condition, and relative benefits and risks of alternative interventions so that patients can participate meaningfully in developing an appropriate plan of action\n- Patients considering keratorefractive surgery should be informed about the possible impact laser vision correction has on reducing contrast sensitivity and decreasing the accuracy of IOP measurements\n- Patients with substantial visual impairment or blindness can be referred for and encouraged to use appropriate vision rehabilitation and social services\n### Follow-Up\n#### Consensus-based Guidelines for Follow-up Glaucoma Status\n| Target IOP Achieved | Progression of Damage | Duration of Control (months) | Approximate Follow-up Interval (months)* |\n|---------------------|-----------------------|------------------------------|------------------------------------------|\n| Yes                 | No                    | ≤6                           | 6                                        |\n| Yes                 | No                    | >6                           | 12                                       |\n| Yes                 | Yes                   | NA                           | 1–2                                      |\n| No                  | Yes                   | NA                           | 1–2                                      |\n| No                  | No                    | NA                           | 3–6                                      |\n*IOP = intraocular pressure; NA = not applicable\n* Patients with more advanced damage or greater lifetime risk from primary open-angle glaucoma may require more frequent evaluations. These intervals are the maximum recommended time between evaluations."
        },
        {
            "id": 1,
            "source": "PPP Summary Benchmarks24full set",
            "content": "## Primary Open-Angle Glaucoma (Initial Evaluation) (continued)\n- Follow-up evaluation on the first postoperative day and at least once during the first 1 to 2 weeks to evaluate visual acuity, IOP, and status of the anterior segment.\n- In the absence of complications, perform additional postoperative visits during a 3-month period to evaluate visual acuity, IOP, and status of the anterior segment.\n- Schedule more frequent follow-up visits, as necessary, for patients with postoperative complications (flat or shallow anterior chamber, early bleb failure, increased inflammation, or Tenon's cyst).\n- Undertake additional treatments as necessary to improve aqueous flow into the bleb and lower IOP if evidence of bleb failure develops, including injection of antifibrotic agents, bleb massage, suture adjustment, release or lysis, or bleb needling.\n- Manage postoperative complications as they develop, such as repair of bleb leak or reformation of a flat anterior chamber.\n- Explain that filtration surgery places the eye at risk for endophthalmitis for the duration of the patient's life, and that if the patient has symptoms of pain and decreased vision and the signs of redness and discharge he or she should notify the ophthalmologist immediately.\n### Patient Education for Patients with Medical Therapy\n- Discuss diagnosis, severity of the disease, prognosis and management plan, and likelihood of lifelong therapy.\n- Educate about eyelid closure or nasolacrimal occlusion when applying topical medications to reduce systemic absorption.\n- Encourage patients to alert their ophthalmologist to physical or emotional changes that occur when taking glaucoma medications.\n## Primary Open-Angle Glaucoma (Follow-up Evaluation)\n### Follow-up Exam History\n- Interval ocular history\n- Interval systemic medical history\n- Side effects of ocular medications\n- Review of pertinent medication use, including time of last administration\n### Follow-up Physical Exam\n- Visual acuity measurement\n- Slit-lamp biomicroscopy\n- IOP measurement\n- Perform gonioscopy if there is a suspicion of angle-closure component, anterior chamber shallowing or anterior chamber angle abnormalities, or if there is an unexplained change in IOP. Perform gonioscopy periodically.\n- ONH and visual field evaluation\n### Adjustment of Therapy\n- Target IOP is not achieved and benefits of a change in therapy outweigh the risks\n- Progressive optic nerve damage despite achieving the target IOP\n- Patient’s intolerant of the prescribed medical regimen\n- Contraindications to individual medications develop\n- Stable optic nerve status and low IOP occur for a prolonged period in a patient taking topical ocular hypotensive agents. Under these circumstances, a carefully monitored attempt to reduce the medical regimen may be appropriate.\n- Downward adjustment of target pressure can be made in the face of progressive optic disc, imaging, or visual field change\n- Upward adjustment of target pressure can be considered if the patient has been stable and if the patient either requires or desires less medication\n### Patient Education\n- Educate about the disease process, the rationale and goals of intervention, the status of their condition, and relative benefits and risks of alternative interventions so that patients can participate meaningfully in developing an appropriate plan of action\n- Patients considering keratorefractive surgery should be informed about the possible impact laser vision correction has on reducing contrast sensitivity and decreasing the accuracy of IOP measurements\n- Patients with substantial visual impairment or blindness can be referred for and encouraged to use appropriate vision rehabilitation and social services\n### Follow-Up\n#### TABLE: Consensus-based Guidelines for Follow-up Glaucoma Status\n| Target IOP Achieved | Progression of Damage | Duration of Control (months) | Approximate Follow-up Interval (months)* |\n|----------------------|-----------------------|-----------------------------|-----------------------------------------|\n| Yes                  | No                    | ≤6                          | 6                                       |\n| Yes                  | No                    | >6                          | 12                                      |\n| Yes                  | Yes                   | NA                          | 1–2                                     |\n| No                   | Yes                   | NA                          | 1–2                                     |\n| No                   | No                    | NA                          | 3–6                                     |\n*IOP = intraocular pressure; NA = not applicable\n*Patients with more advanced damage or greater lifetime risk from primary open-angle glaucoma may require more frequent evaluations. These intervals are the maximum recommended time between evaluations."
        },
        {
            "id": 2,
            "source": "Primary Open-Angle Glaucoma PPP",
            "content": "## Endoscopic Cyclophotocoagulation\nEndoscopic cyclophotocoagulation<sup>633, 634, 637</sup> may be combined with cataract surgery. One randomized trial comparing cataract surgery combined with either ECP or trabeculectomy suggested that IOP lowering efficacy is similar for both,<sup>638</sup> and another study comparing ECP with the Ahmed drainage implant also showed comparable efficacy in lowering IOP, although the rate of complication with the latter surgery was higher.<sup>639</sup> A 2019 Cochrane Systematic Review found inconclusive evidence whether cyclodestructive procedures for refractory glaucoma result in better outcomes and fewer complications than other glaucoma treatments, or whether one cyclodestructive procedure is better than another.<sup>640</sup> Another 2019 Cochrane Systematic Review identified no studies on the effects of endocyclophotocoagulation for open-angle glaucoma.<sup>641</sup> Additional randomized clinical trials are needed to further elucidate the merits of each type of cyclophotocoagulation relative to one another as well as to other types of glaucoma surgery.<sup>640, 641</sup> Therefore, the selection of cyclophotocoagulation over other procedures should be left to the discretion of the treating ophthalmologist, in consultation with the individual patient.\n*(I., Insufficient Quality, Discretionary Recommendation)*\n## Other Therapeutic Considerations\nThere is a growing interest in complementary and alternative medicinal approaches to the treatment of glaucoma. There is a lack of conclusive scientific evidence that herbal medicines or nutritional supplements are beneficial in treating glaucoma.<sup>642–645</sup> Two reviews of the scientific evidence by the American Academy of Ophthalmology and the American Glaucoma Society found no support for increased benefit or diminished risk with the use of marijuana to treat glaucoma compared with conventional medications.<sup>646, 647</sup> Results from the National Health and Nutrition Examination Survey (NHANES) suggest that higher intensity exercise may reduce the risk of developing glaucoma.<sup>648</sup>\n## Follow-up Evaluation\nGuidelines for follow-up of patients with POAG are summarized in Table 7. These recommendations apply to ongoing glaucoma management and not to visits for other purposes. The purpose of follow-up examination is to evaluate IOP level, visual field status, and optic disc appearance as well as ONH, RNFL, and macular imaging to determine if progressive damage has occurred.\n#### Table 7: Consensus-Based Guidelines for Follow-up Glaucoma Status\n| Target IOP Achieved | Progression of Damage | Duration of Control (mos) | Approximate Follow-up Interval (mos)\\* |\n|----------------------|-----------------------|----------------------------|---------------------------------------|\n| Yes                 | No                    | ≤6                         | 6                                     |\n| Yes                 | No                    | >6                         | 6–12                                  |\n| Yes                 | Yes                   | NA                         | 1–2                                   |\n| No                  | Yes                   | NA                         | 1–2                                   |\n| No                  | No                    | NA                         | 3–6                                   |\n\\* IOP = intraocular pressure; NA = not applicable\n\\** Patients with more advanced damage or greater lifetime risk from primary open-angle glaucoma may require more frequent evaluations. These intervals are the maximum recommended time between evaluations.\n## History\nThe following interval history can be elicited at POAG follow-up visits:\n- Interval ocular history"
        }
    ],
    "QuestionID": "2",
    "llm_name": "deepseek-chat",
    "Question": "What lifestyle changes should I make to prevent further damage to my eyes?",
    "clinical_data": {
        "Age": 79.0,
        "Gender": "Female",
        "AdmissionDate": "2024-06-30T00:00:00",
        "DischargeDate": "2024-07-05T00:00:00",
        "AdmissionDiagnosis": "1. Left eye primary acute angle-closure glaucoma; 2. Left eye senile cataract",
        "DischargeDiagnosis": "1. Left eye primary acute angle-closure glaucoma; 2. Left eye senile cataract",
        "ClinicalHistory": "Chief Complaint: Sudden onset of distending pain and blurred vision in the left eye for 4 days.\nHistory of Present Illness: Four days ago, the patient experienced sudden onset of distending pain in the left eye without obvious precipitating factors, accompanied by a rapid decrease in vision. Both distant and near vision were unclear, accompanied by irritative symptoms such as eye redness, photophobia, and tearing, as well as ipsilateral headache and nausea. Denies history of ocular trauma. As symptoms persisted without relief, the patient came to our hospital today for treatment. After relevant examinations in the outpatient clinic, the patient was admitted with a provisional diagnosis of \"1. Left eye primary acute angle-closure glaucoma; 2. Bilateral pseudophakia.\" During the course of the illness, there was no fever or cough. Appetite and sleep were poor, but bowel movements and urination were normal.\nPast Medical History and Surgical/Trauma History: General condition: Usually in general good health. Denies history of chronic diseases such as diabetes mellitus and coronary heart disease; denies history of blood transfusion or trauma. Denies history of infectious diseases such as hepatitis, tuberculosis, bacillary dysentery, and typhoid fever. Immunizations completed on schedule. Denies allergies to sulfonamide drugs, streptomycin, gentamicin, penicillin, cephalosporins, other medications, or any known food allergies.\nOphthalmic Examination: Vod 0.4, Vos 0.1. IOP OD Tn, OS T+2. Right eye: conjunctiva without hyperemia, cornea clear, peripheral anterior chamber shallow, aqueous humor clear, pupil round with a diameter of approximately 3mm, reactive to light (+), lens turbid, fundus visible with retina attached, no obvious hemorrhage or exudation seen. Left eye: conjunctival mixed hyperemia (++), corneal opacity and edema, subepithelial bullae, KP (-), anterior chamber shallow, peripheral anterior chamber <1/3 CT, aqueous flare (+), pupil round with a diameter of approximately 4mm, reactive to light (+), lens turbid, fundus not visible.",
        "DifferentialDiagnosis": "1. Acute iridocyclitis: Sudden onset of eye redness, eye pain, varying degrees of vision loss, intraocular pressure usually not elevated, significant anterior chamber inflammatory reaction, pupil constricted and irregular in shape.\n2. Glaucomatocyclitic crisis: Patients are mostly young and middle-aged adults, acute sharp increase in intraocular pressure, local irritation symptoms are mild, anterior chamber is not shallow, open angle, mutton-fat KPs on the posterior cornea."
    },
    "llm_answer_type": "LLM_HypotheticalRAG_Response",
    "temperature": 0
}